CLDX Q1 2026 Earnings Slight EPS Miss as DevelopmentStage Biotech Continues NoRevenue Phase SUZ Q1 2026 Earnings Strong EPS Beat Driven by Operational Efficiency and Favorable Pulp Market ATO Q1 2026 Earnings EPS Beat Amid Natural Gas Utility Strength LCTX Q1 2026 Earnings EPS Miss Weighs on Sentiment as ClinicalStage Biotech Continues Pipeline Progress KUST Q4 2025 Earnings EPS Misses Estimates by a Wide Margin Amid Operational Challenges HOG Q1 2026 Earnings EPS Beats Estimates by 117 as Shares Rise